Interferon gamma in autoimmunity: A complicated player on a complex stage.

[1]  D. Denning,et al.  Clinical implications of interferon‐γ genetic and epigenetic variants , 2014, Immunology.

[2]  H. Spits,et al.  Human innate lymphoid cells. , 2014, Blood.

[3]  T. Muchamuel,et al.  Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis , 2014, EMBO molecular medicine.

[4]  C. Qian,et al.  Identification of IFN-γ-producing innate B cells , 2013, Cell Research.

[5]  Graham M Lord,et al.  T-bet: a bridge between innate and adaptive immunity , 2013, Nature Reviews Immunology.

[6]  B. Becher,et al.  Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell–mediated dendrite and synapse loss , 2013, The Journal of experimental medicine.

[7]  C. Lamaze,et al.  Interferon Gamma Receptor: The Beginning of the Journey , 2013, Front. Immunol..

[8]  Cara L. Wilhelm,et al.  TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogens , 2013, Proceedings of the National Academy of Sciences.

[9]  M. Wright,et al.  Enhanced Dendritic Cell-Mediated Antigen-Specific CD4+ T Cell Responses: IFN-Gamma Aids TLR Stimulation , 2013, Journal of Drug Delivery.

[10]  T. Aune,et al.  Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ , 2013, Front. Immunol..

[11]  E. Sampaio,et al.  Interferon Alpha Treatment of Patients with Impaired Interferon Gamma Signaling , 2013, Journal of Clinical Immunology.

[12]  L. Rönnblom,et al.  The interferon signature in autoimmune diseases , 2013, Current opinion in rheumatology.

[13]  Xin Li,et al.  Pre‐existing central nervous system lesions negate cytokine requirements for regional experimental autoimmune encephalomyelitis development , 2013, Immunology.

[14]  Howard Y. Chang,et al.  The NeST Long ncRNA Controls Microbial Susceptibility and Epigenetic Activation of the Interferon-γ Locus , 2013, Cell.

[15]  M. Groettrup,et al.  The immunoproteasome in antigen processing and other immunological functions. , 2013, Current opinion in immunology.

[16]  R. Locksley,et al.  Innate lymphoid cells — a proposal for uniform nomenclature , 2013, Nature Reviews Immunology.

[17]  T. Decker,et al.  The regulation of inflammation by interferons and their STATs , 2013, JAK-STAT.

[18]  Simon Yu,et al.  INTERFEROME v2.0: an updated database of annotated interferon-regulated genes , 2012, Nucleic Acids Res..

[19]  E. A. Volpe,et al.  Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice , 2012, Arthritis Research & Therapy.

[20]  D. Campbell,et al.  Type‐1 immunity drives early lethality in scurfy mice , 2012, European journal of immunology.

[21]  T. Aune,et al.  Cutting Edge: Influence of Tmevpg1, a Long Intergenic Noncoding RNA, on the Expression of Ifng by Th1 Cells , 2012, The Journal of Immunology.

[22]  P. Rodriguez,et al.  Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives , 2012, Immunological investigations.

[23]  A. R. Shenoy,et al.  IFN-γ Elicits Macrophage Autophagy via the p38 MAPK Signaling Pathway , 2012, The Journal of Immunology.

[24]  A. Sher,et al.  NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. , 2012, Immunity.

[25]  D. Pleasure,et al.  IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci , 2012, Journal of Neuroinflammation.

[26]  R. Sosa,et al.  The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[27]  W. Zou,et al.  Dual biological effects of the cytokines interleukin-10 and interferon-γ , 2011, Cancer Immunology, Immunotherapy.

[28]  J. Li,et al.  Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[29]  Jonathan D. Cherry,et al.  Oligodendrocyte Progenitors Reversibly Exit the Cell Cycle and Give Rise to Astrocytes in Response to Interferon-γ , 2011, The Journal of Neuroscience.

[30]  K. Shimoyama,et al.  Activation of the Interferon Pathway in Peripheral Blood of Patients with Sjögren’s Syndrome , 2011, The Journal of Rheumatology.

[31]  C. Loddenkemper,et al.  Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis , 2011, International journal of cancer.

[32]  Wen‐Teng Chang,et al.  Glycogen synthase kinase‐3β indirectly facilitates interferon‐γ‐induced nuclear factor‐κB activation and nitric oxide biosynthesis , 2010, Journal of cellular biochemistry.

[33]  P. Meltzer,et al.  Interferon-γ links UV to melanocyte activation and promotes melanomagenesis , 2010, Nature.

[34]  Wensheng Lin,et al.  Interferon‐γ inhibits central nervous system myelination through both STAT1‐dependent and STAT1‐independent pathways , 2010, Journal of neuroscience research.

[35]  P. Kloetzel,et al.  Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress , 2010, Cell.

[36]  P. Bartlett,et al.  Endogenous Interferon γ Directly Regulates Neural Precursors in the Non-Inflammatory Brain , 2010, The Journal of Neuroscience.

[37]  T. Mcclanahan,et al.  Human Th17 Cells Comprise Heterogeneous Subsets Including IFN-γ–Producing Cells with Distinct Properties from the Th1 Lineage , 2010, The Journal of Immunology.

[38]  Simon A. Jones,et al.  Interferon-γ inhibits interleukin-1β-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis , 2010, Arthritis research & therapy.

[39]  T. Glant,et al.  IFN-γ Regulates the Requirement for IL-17 in Proteoglycan-Induced Arthritis , 2009, The Journal of Immunology.

[40]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[41]  P. Duquette,et al.  Preferential recruitment of interferon‐γ–expressing TH17 cells in multiple sclerosis , 2009, Annals of neurology.

[42]  Miriam V. Liscovsky,et al.  Interferon‐γ priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages , 2009, Immunology.

[43]  J. Goverman.  Autoimmune T cell responses in the central nervous system , 2009, Nature Reviews Immunology.

[44]  Daniel J. Campbell,et al.  T-bet controls regulatory T cell homeostasis and function during type-1 inflammation , 2009, Nature Immunology.

[45]  B. Clotet,et al.  Secretion of interferon‐γ by human macrophages demonstrated at the single‐cell level after costimulation with interleukin (IL)‐12 plus IL‐18 , 2009, Immunology.

[46]  C. Akdis,et al.  Regulation of the foxp3 Gene by the Th1 Cytokines: The Role of IL-27-Induced STAT11 , 2009, The Journal of Immunology.

[47]  S. Polumuri,et al.  Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses. , 2009, Arthritis and rheumatism.

[48]  Jiahuai Han,et al.  Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. , 2008, Immunity.

[49]  G. Prendergast,et al.  Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase , 2008, Proceedings of the National Academy of Sciences.

[50]  J. Russell,et al.  Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis , 2008, The Journal of experimental medicine.

[51]  D. Levy,et al.  IFNgamma signaling-does it mean JAK-STAT? , 2008, Cytokine & growth factor reviews.

[52]  Eugene Y. Kim,et al.  Regulation of autoimmune inflammation by pro-inflammatory cytokines. , 2008, Immunology letters.

[53]  James T. Elder,et al.  Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis1 , 2008, The Journal of Immunology.

[54]  L. Ivashkiv,et al.  IFN-γ and STAT1 Arrest Monocyte Migration and Modulate RAC/CDC42 Pathways1 , 2008, The Journal of Immunology.

[55]  E. Riley,et al.  IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.

[56]  I. Kerr,et al.  Multiple kinases in the interferon-γ response , 2008, Proceedings of the National Academy of Sciences.

[57]  J. Goverman,et al.  Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells , 2008, Nature Medicine.

[58]  S. McColl,et al.  IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. , 2007, Blood.

[59]  K. Elkon,et al.  Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. , 2007, Arthritis and rheumatism.

[60]  Hubertus Hochrein,et al.  Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. , 2007, Blood.

[61]  D. Ron,et al.  The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. , 2007, The Journal of clinical investigation.

[62]  Ningli Li,et al.  Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25– T cells to CD4+ Tregs , 2006 .

[63]  J. Pedrosa,et al.  Cutting Edge: IFN-γ Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection1 , 2006, The Journal of Immunology.

[64]  D. Ron,et al.  Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress , 2006 .

[65]  D. Eizirik,et al.  Interferon-γ potentiates endoplasmic reticulum stress-induced death by reducing pancreatic beta cell defence mechanisms , 2006, Diabetologia.

[66]  K. Wood,et al.  Interferon γ: a crucial role in the function of induced regulatory T cells in vivo , 2006 .

[67]  S. Cha,et al.  Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. , 2006, Journal of autoimmunity.

[68]  O. Takikawa.  Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. , 2005, Biochemical and biophysical research communications.

[69]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[70]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[71]  Elke Krüger,et al.  Interferon‐γ, the functional plasticity of the ubiquitin–proteasome system, and MHC class I antigen processing , 2005, Immunological reviews.

[72]  P. Kloetzel,et al.  IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Harty,et al.  Dynamic Regulation of IFN-γ Signaling in Antigen-Specific CD8+ T Cells Responding to Infection1 , 2005, The Journal of Immunology.

[74]  D. Ron,et al.  Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-γ , 2005, The Journal of cell biology.

[75]  I. Jonassen,et al.  Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. , 2005, Arthritis and rheumatism.

[76]  G. Mayrhofer,et al.  Blockade of IFN‐γ does not affect the arthritogenicity of T cells generated during the induction of adjuvant arthritis but exacerbates the polyarthritis produced by adoptive transfer of arthritogenic effector cells , 2005, Immunology and cell biology.

[77]  C. Bogdan,et al.  Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN-gamma in IL-12/IL-18-stimulated mouse macrophage populations. , 2005, Blood.

[78]  Shaohua Chen,et al.  IFN-γ Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[79]  J. Brayer,et al.  A Dual Role for Interferon‐γ in the Pathogenesis of Sjögren's Syndrome‐Like Autoimmune Exocrinopathy in the Nonobese Diabetic Mouse , 2004, Scandinavian journal of immunology.

[80]  H. Mcdevitt,et al.  Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[81]  S. Holland,et al.  Long-Term Interferon-γ Therapy for Patients with Chronic Granulomatous Disease , 2004 .

[82]  D. Bredesen,et al.  Coupling endoplasmic reticulum stress to the cell death program , 2004, Cell Death and Differentiation.

[83]  S. Perlman,et al.  Bystander CD8 T-Cell-Mediated Demyelination is Interferon-γ-Dependent in a Coronavirus Model of Multiple Sclerosis , 2004, The American Journal of Pathology.

[84]  G. Atkins,et al.  Role of interferon‐γ and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection , 2003, Neuropathology and applied neurobiology.

[85]  Yoshifumi Watanabe,et al.  Interferon‐γ induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis , 2003, Journal of cellular biochemistry.

[86]  Xiaoyu Hu,et al.  Sensitization of IFN-γ Jak-STAT signaling during macrophage activation , 2002, Nature Immunology.

[87]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[88]  O. Favorova,et al.  Randomized study of antibodies to IFN-g and TNF-a in secondary progressive multiple sclerosis , 2001 .

[89]  J. Casanova,et al.  Recurrent Mycobacterium avium Osteomyelitis Associated With a Novel Dominant Interferon Gamma Receptor Mutation , 2001, Pediatrics.

[90]  C. Bogdan,et al.  The Production of IFN-γ by IL-12/IL-18-Activated Macrophages Requires STAT4 Signaling and Is Inhibited by IL-41 , 2001, The Journal of Immunology.

[91]  R. Döffinger,et al.  Human interferon‐g‐mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion , 2000, Immunological reviews.

[92]  P. Rothman,et al.  Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. , 2000, Diabetes.

[93]  P. Ye,et al.  Interferon-γ Protects against Cuprizone-Induced Demyelination , 2000, Molecular and Cellular Neuroscience.

[94]  J. Newcombe,et al.  Expression of the interferon‐γ‐inducible chemokines IP‐10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions , 2000, Neuropathology and applied neurobiology.

[95]  Mikhail Chernov,et al.  Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .

[96]  J. Casanova,et al.  Surface Expression of the IFN-γR2 Chain Is Regulated by Intracellular Trafficking in Human T Lymphocytes1 , 2000, The Journal of Immunology.

[97]  K Eichmann,et al.  Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. , 1999, Journal of immunology.

[98]  C. de Wolf‐Peeters,et al.  Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. , 1999, Journal of immunology.

[99]  A. Yoshimura,et al.  SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.

[100]  N. Young,et al.  Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential. , 1998, Experimental hematology.

[101]  R. Schreiber,et al.  IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. , 1998, The Journal of clinical investigation.

[102]  H. Okamura,et al.  LPS-Stimulated SJL Macrophages Produce IL-12 and IL-18 That Inhibit IgE Production In Vitro by Induction of IFN-γ Production from CD3intIL-2Rβ+ T Cells , 1998, The Journal of Immunology.

[103]  J. Davoust,et al.  Actin microfilaments control the MHC class II antigen presentation pathway in B cells. , 1998, Journal of cell science.

[104]  D. Balomenos,et al.  The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. , 1998, Journal of immunology.

[105]  M. Reitz,et al.  Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. , 1998, Blood.

[106]  Klaus Eichmann,et al.  Murine Macrophages Secrete Interferon γ upon Combined Stimulation with Interleukin (IL)-12 and IL-18: A Novel Pathway of Autocrine Macrophage Activation , 1998, The Journal of experimental medicine.

[107]  D. Balomenos,et al.  Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. , 1998, The Journal of clinical investigation.

[108]  N. Young,et al.  Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. , 1997, Blood.

[109]  V. Cattell,et al.  Antinuclear Autoantibodies and Lupus Nephritis in Transgenic Mice Expressing Interferon γ in the Epidermis , 1997, The Journal of experimental medicine.

[110]  G. Forni,et al.  Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones. , 1997, Journal of immunology.

[111]  P. Fitzpatrick,et al.  Interferon-γ Modulates a p53-independent Apoptotic Pathway and Apoptosis-related Gene Expression* , 1997, The Journal of Biological Chemistry.

[112]  S. Huang,et al.  High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. , 1997, Journal of immunology.

[113]  A. Billiau,et al.  Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.

[114]  D. Kalvakolanu,et al.  Interferon gamma-induced transcription of the murine ISGF3gamma (p48) gene is mediated by novel factors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[115]  S. Pestka,et al.  Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. , 1996, Journal of immunology.

[116]  T. Owens,et al.  Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.

[117]  N. Young,et al.  Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. , 1996, Blood.

[118]  Xin-Yuan Fu,et al.  Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1 , 1996, Science.

[119]  B. Popko,et al.  Targeted CNS Expression of Interferon-γ in Transgenic Mice Leads to Hypomyelination, Reactive Gliosis, and Abnormal Cerebellar Development , 1996, Molecular and Cellular Neuroscience.

[120]  N. Young,et al.  Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. , 1995, Blood.

[121]  K. Pavelko,et al.  Gamma interferon is critical for resistance to Theiler's virus-induced demyelination , 1995, Journal of virology.

[122]  R. Schreiber,et al.  Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[123]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[124]  M. Modolell,et al.  Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines , 1995, European journal of immunology.

[125]  C. Raine,et al.  The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.

[126]  N. Calcutt,et al.  Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction , 1995, The Journal of experimental medicine.

[127]  B. Mach,et al.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. , 1994, Science.

[128]  G. Forni,et al.  Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis. , 1994, Journal of immunology.

[129]  A. Nussler,et al.  Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. , 1994, The Journal of biological chemistry.

[130]  G. Karupiah,et al.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. , 1993, Science.

[131]  A. Issekutz,et al.  Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. , 1993, Journal of immunology.

[132]  A. Deisseroth,et al.  Interferon-gamma priming effects in the activation and deactivation of ISGF3 in K562 cells. , 1993, The Journal of biological chemistry.

[133]  R. Gentz,et al.  Modulation of interferon‐γ receptor during human T lymphocyte alloactivation , 1993 .

[134]  K. Yasumoto,et al.  Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. , 1992, The Journal of biological chemistry.

[135]  G. Forni,et al.  Distribution of interferon‐γ receptor in human tissues , 1992 .

[136]  J. Finke,et al.  IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages. , 1992, Journal of immunology.

[137]  G. Trinchieri,et al.  Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and gamma-interferon. , 1992, Cancer research.

[138]  V. Barnaba,et al.  Tumor Necrosis Factor‐Alpha and Interferon‐Gamma Synthesis by Cerebrospinal Fluid‐Derived T Cell Clones in Multiple Sclerosis , 1992, Annals of the New York Academy of Sciences.

[139]  G. Forni,et al.  Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation. , 1991, Journal of immunology.

[140]  P. Bedossa,et al.  Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.

[141]  L. Harrison,et al.  Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. , 1991, The Journal of clinical investigation.

[142]  C. Janeway,et al.  Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance , 1990, The Journal of experimental medicine.

[143]  H. Nakajima,et al.  The effect of treatment with interferon‐gamma on type II collagen‐induced arthritis , 1990, Clinical and experimental immunology.

[144]  N. Sarvetnick,et al.  Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ , 1990, Nature.

[145]  J. Finke,et al.  Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. , 1990, The Journal of biological chemistry.

[146]  R. Jonsson,et al.  Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. , 1988, Arthritis and rheumatism.

[147]  C. June,et al.  Examination of the inhibitory and stimulatory effects of IFN-α, -β, and -γ on human B-cell proliferation induced by various B-cell mitogens , 1988 .

[148]  S. Landolfo,et al.  Interferon‐γ is not an antiviral, but a growth‐promoting factor for t lymphocytes , 1988 .

[149]  H. Mcdevitt,et al.  In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon , 1987, The Journal of experimental medicine.

[150]  R. Hirsch,et al.  Treatment of multiple sclerosis with gamma interferon , 1987, Neurology.

[151]  W. Paul,et al.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. , 1987, Science.

[152]  A. Freedman,et al.  Preexposure of resting B cells to interferon-gamma enhances their proliferative response to subsequent activation signals. , 1987, Cellular immunology.

[153]  R. Hirsch,et al.  Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferonin vitro , 1985, Journal of Clinical Immunology.

[154]  F. Finkelman,et al.  Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. , 1985, Journal of immunology.

[155]  W. Fierz,et al.  Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. , 1985, Journal of immunology.

[156]  W. Fiers,et al.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[157]  C. Nathan,et al.  Activation of human macrophages. Comparison of other cytokines with interferon-gamma , 1984, The Journal of experimental medicine.

[158]  W. Fiers,et al.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon , 1983, Nature.

[159]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[160]  M. Fellous,et al.  Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells , 1982, Nature.

[161]  I. Gresser,et al.  Lethality of interferon preparations for newborn mice , 1975, Nature.

[162]  G. Mackaness.  THE INFLUENCE OF IMMUNOLOGICALLY COMMITTED LYMPHOID CELLS ON MACROPHAGE ACTIVITY IN VIVO , 1969, The Journal of experimental medicine.

[163]  E. Cadman,et al.  Sjögren's Syndrome , 1953, Medicine illustrated.

[164]  N. Roescher.  Local gene therapy and the identification of therapeutic targets in Sjögren’s syndrome , 2012 .

[165]  E. Ortega,et al.  Interferon gamma induces actin polymerization, Rac1 activation and down regulates phagocytosis in human monocytic cells. , 2012, Cytokine.

[166]  L. Ivashkiv,et al.  IFN-gamma and STAT1 arrest monocyte migration and modulate RAC/CDC42 pathways. , 2008, Journal of immunology.

[167]  K. Wood,et al.  Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. , 2006, Trends in immunology.

[168]  X. Chen,et al.  Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. , 2006, The Journal of clinical investigation.

[169]  D. Ron,et al.  Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. , 2006, Brain : a journal of neurology.

[170]  J. Harty,et al.  Dynamic regulation of IFN-gamma signaling in antigen-specific CD8+ T cells responding to infection. , 2005, Journal of immunology.

[171]  Shaohua Chen,et al.  IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis. , 2005, Journal of immunology.

[172]  S. Holland,et al.  Long-term interferon-gamma therapy for patients with chronic granulomatous disease. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[173]  Lionel B Ivashkiv,et al.  Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. , 2002, Nature immunology.

[174]  B. Croker,et al.  Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. , 2001, Kidney international.

[175]  O. Favorova,et al.  Randomized study of antibodies to IFN-gamma and TNF-alpha in secondary progressive multiple sclerosis. , 2001, Multiple sclerosis.

[176]  P. Ye,et al.  Interferon-gamma protects against cuprizone-induced demyelination. , 2000, Molecular and cellular neurosciences.

[177]  G R Stark,et al.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. , 2000, The EMBO journal.

[178]  H. Okamura,et al.  LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells. , 1998, Journal of immunology.

[179]  Y. Iwakura,et al.  Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon- (cid:103) production from activated B cells , 1997 .

[180]  F. Watt,et al.  Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. , 1997, The Journal of investigative dermatology.

[181]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[182]  R. Gentz,et al.  Modulation of interferon-gamma receptor during human T lymphocyte alloactivation. , 1993, European journal of immunology.

[183]  R. Knobler,et al.  Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. , 1993, Autoimmunity.

[184]  G. Forni,et al.  Distribution of interferon-gamma receptor in human tissues. , 1992, European journal of immunology.

[185]  N. Sarvetnick,et al.  Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. , 1990, Nature.

[186]  C. June,et al.  Examination of the inhibitory and stimulatory effects of IFN-alpha, -beta, and -gamma on human B-cell proliferation induced by various B-cell mitogens. , 1988, Clinical immunology and immunopathology.

[187]  S. Landolfo,et al.  Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes. , 1988, European journal of immunology.